000 | 01884 a2200553 4500 | ||
---|---|---|---|
005 | 20250515071901.0 | ||
264 | 0 | _c20070823 | |
008 | 200708s 0 0 eng d | ||
022 | _a1347-8613 | ||
024 | 7 |
_a10.1254/jphs.fp0061441 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFerrer-Lorente, Raquel | |
245 | 0 | 0 |
_aEffects of combined oleoyl-estrone and rimonabant on overweight rats. _h[electronic resource] |
260 |
_bJournal of pharmacological sciences _cJun 2007 |
||
300 |
_a176-82 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Obesity Agents _xpharmacology |
650 | 0 | 4 |
_aAppetite _xdrug effects |
650 | 0 | 4 |
_aBlood Glucose _xdrug effects |
650 | 0 | 4 |
_aCholecystokinin _xblood |
650 | 0 | 4 |
_aCholesterol _xblood |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 |
_aEating _xdrug effects |
650 | 0 | 4 |
_aEnergy Metabolism _xdrug effects |
650 | 0 | 4 |
_aEstrone _xanalogs & derivatives |
650 | 0 | 4 |
_aFatty Acids, Nonesterified _xblood |
650 | 0 | 4 | _aGhrelin |
650 | 0 | 4 |
_aGlucagon-Like Peptide 1 _xdrug effects |
650 | 0 | 4 |
_aInsulin _xblood |
650 | 0 | 4 |
_aLeptin _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aObesity _xdrug therapy |
650 | 0 | 4 |
_aOleic Acids _xpharmacology |
650 | 0 | 4 |
_aOverweight _xdrug effects |
650 | 0 | 4 |
_aPeptide Hormones _xblood |
650 | 0 | 4 |
_aPiperidines _xpharmacology |
650 | 0 | 4 |
_aPyrazoles _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 | _aRimonabant |
650 | 0 | 4 |
_aTriglycerides _xblood |
700 | 1 | _aCabot, Cristina | |
700 | 1 | _aFernández-López, José-Antonio | |
700 | 1 | _aAlemany, Marià | |
773 | 0 |
_tJournal of pharmacological sciences _gvol. 104 _gno. 2 _gp. 176-82 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1254/jphs.fp0061441 _zAvailable from publisher's website |
999 |
_c17096856 _d17096856 |